SCHEMBL29311295

SCHEMBL29311295

c1ccc(-c2nc3ccc(-c4nc(-c5ccc6c(c5)sc5ccccc56)nc(-n5c6ccccc6c6ccccc65)n4)cc3s2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 10/20 0.47
▸ KDM4E B2RXH2 6/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ NFKB1 P19838 2/20 0.45
▸ NFKB2 Q00653 2/20 0.45
▸ RELA Q04206 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ MAPT P10636 6/20 0.44
▸ GAA P10253 5/20 0.44
▸ GLA P06280 4/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ PKM P14618 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ RAB9A P51151 6/20 0.40
▸ NPC1 O15118 5/20 0.40
▸ PAX8 Q06710 2/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ MMP8 P22894 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29311356 0.93 APP (0.41) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL25459877 0.92 KDM4E (0.50) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL29311292 0.91 KDM4E (0.47) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL29311290 0.91 KDM4E (0.49) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL27049292 0.91 KDM4E (0.51) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL29311367 0.89 APP (0.43) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL27049592 0.89 KDM4E (0.47) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL29311291 0.89 KDM4E (0.47) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL16811605 0.89 HPGD (0.39) KDM4ESMN1; SMN2LMNAMAPTGLA
SCHEMBL29311297 0.88 APP (0.42) APPKDM4ESMN1; SMN2NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237519-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2024-07-11 — — US disclosed
US-20240237519-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2024-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240237519-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND NLRP3, NLRP1, TYR APP 727/4885KDM4E 1611/4885SMN1; SMN2 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback